Experimental Validation of Antiobesogenic and Osteoprotective Efficacy of Ginsenoside CK via Targeting Lipid and Atherosclerosis Pathways
The present study explored the possible antiobesogenic and osteoprotective properties of the gut metabolite ginsenoside CK to clarify its influence on lipid and atherosclerosis pathways, thereby validating previously published hypotheses. These hypotheses were validated by harvesting and cultivating...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Life |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-1729/15/1/41 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832588109174276096 |
|---|---|
| author | Md. Niaj Morshed Reshmi Akter Imran Mahmud Ah-Yeong Gwon Jin Woo Jeang Yeong-Geun Lee Dae Won Park Deok Chun Yang Yeon Ju Kim Se-Chan Kang |
| author_facet | Md. Niaj Morshed Reshmi Akter Imran Mahmud Ah-Yeong Gwon Jin Woo Jeang Yeong-Geun Lee Dae Won Park Deok Chun Yang Yeon Ju Kim Se-Chan Kang |
| author_sort | Md. Niaj Morshed |
| collection | DOAJ |
| description | The present study explored the possible antiobesogenic and osteoprotective properties of the gut metabolite ginsenoside CK to clarify its influence on lipid and atherosclerosis pathways, thereby validating previously published hypotheses. These hypotheses were validated by harvesting and cultivating 3T3-L1 and MC3T3-E1 in adipogenic and osteogenic media with varying concentrations of CK. We assessed the differentiation of adipocytes and osteoblasts in these cell lines by applying the most effective doses of CK that we initially selected. Using 3T3-L1 adipocytes in vitro assessments, CK could effectively decrease intracellular lipid accumulation, inhibit α-glucosidase enzyme, increase 2-NBDG glucose uptake, reduce inflammation-associated cytokines (<i>TNFα</i>, and <i>IL-6</i>), adipogenic regulatory genes (<i>PPARγ</i>, <i>FAS</i>, <i>C/EBPα</i>), lipogenic gene <i>LPL</i>, and increase the expression of thermogenic gene <i>UCP1</i>. Additionally, CK treatment induced osteoblast development in MC3T3-E1 cells as shown by increased mineralization and calcium distribution, collagen content, alkaline phosphatase activity, and decreased inflammatory cytokines <i>TNFα</i>, and <i>IL-6</i> and increased the regulated expressions of osteogenic genes including <i>Runx2</i>, <i>ALP</i>, <i>BGLAP</i>, <i>OCN</i>, and <i>Col1a1</i>. Significantly, as a major inhibitory regulator, the <i>TP</i><sup>53</sup> gene was down-regulated in both 3T3-L1 and MC3T3E1 cells after the treatment of CK. These encouraging results demonstrate the possible use of CK as an innovative treatment for controlling obesity and osteoporosis, targeting the underlying mechanisms of obesogenic and bone loss. Further studies are necessary to explore the clinical implications of these results and the potential of CK in future treatment strategies. This research highlights the promise of CK in addressing significant health issues. |
| format | Article |
| id | doaj-art-0f7eaced58ae4f2897586f41649c516b |
| institution | Kabale University |
| issn | 2075-1729 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Life |
| spelling | doaj-art-0f7eaced58ae4f2897586f41649c516b2025-01-24T13:38:33ZengMDPI AGLife2075-17292024-12-011514110.3390/life15010041Experimental Validation of Antiobesogenic and Osteoprotective Efficacy of Ginsenoside CK via Targeting Lipid and Atherosclerosis PathwaysMd. Niaj Morshed0Reshmi Akter1Imran Mahmud2Ah-Yeong Gwon3Jin Woo Jeang4Yeong-Geun Lee5Dae Won Park6Deok Chun Yang7Yeon Ju Kim8Se-Chan Kang9Department of Biopharmaceutical Biotechnology, College of Life Science, Kyung Hee University, Yongin-si 17104, Gyeonggi-do, Republic of KoreaGraduate School of Biotechnology, College of Life Sciences, Kyung Hee University, Yongin-si 17104, Gyeonggi-do, Republic of KoreaDepartment of Biochemistry & Biotechnology, University of Turku, 20014 Turku, FinlandGraduate School of Biotechnology, College of Life Sciences, Kyung Hee University, Yongin-si 17104, Gyeonggi-do, Republic of KoreaGraduate School of Biotechnology, College of Life Sciences, Kyung Hee University, Yongin-si 17104, Gyeonggi-do, Republic of KoreaGraduate School of Biotechnology, College of Life Sciences, Kyung Hee University, Yongin-si 17104, Gyeonggi-do, Republic of KoreaGraduate School of Biotechnology, College of Life Sciences, Kyung Hee University, Yongin-si 17104, Gyeonggi-do, Republic of KoreaGraduate School of Biotechnology, College of Life Sciences, Kyung Hee University, Yongin-si 17104, Gyeonggi-do, Republic of KoreaGraduate School of Biotechnology, College of Life Sciences, Kyung Hee University, Yongin-si 17104, Gyeonggi-do, Republic of KoreaGraduate School of Biotechnology, College of Life Sciences, Kyung Hee University, Yongin-si 17104, Gyeonggi-do, Republic of KoreaThe present study explored the possible antiobesogenic and osteoprotective properties of the gut metabolite ginsenoside CK to clarify its influence on lipid and atherosclerosis pathways, thereby validating previously published hypotheses. These hypotheses were validated by harvesting and cultivating 3T3-L1 and MC3T3-E1 in adipogenic and osteogenic media with varying concentrations of CK. We assessed the differentiation of adipocytes and osteoblasts in these cell lines by applying the most effective doses of CK that we initially selected. Using 3T3-L1 adipocytes in vitro assessments, CK could effectively decrease intracellular lipid accumulation, inhibit α-glucosidase enzyme, increase 2-NBDG glucose uptake, reduce inflammation-associated cytokines (<i>TNFα</i>, and <i>IL-6</i>), adipogenic regulatory genes (<i>PPARγ</i>, <i>FAS</i>, <i>C/EBPα</i>), lipogenic gene <i>LPL</i>, and increase the expression of thermogenic gene <i>UCP1</i>. Additionally, CK treatment induced osteoblast development in MC3T3-E1 cells as shown by increased mineralization and calcium distribution, collagen content, alkaline phosphatase activity, and decreased inflammatory cytokines <i>TNFα</i>, and <i>IL-6</i> and increased the regulated expressions of osteogenic genes including <i>Runx2</i>, <i>ALP</i>, <i>BGLAP</i>, <i>OCN</i>, and <i>Col1a1</i>. Significantly, as a major inhibitory regulator, the <i>TP</i><sup>53</sup> gene was down-regulated in both 3T3-L1 and MC3T3E1 cells after the treatment of CK. These encouraging results demonstrate the possible use of CK as an innovative treatment for controlling obesity and osteoporosis, targeting the underlying mechanisms of obesogenic and bone loss. Further studies are necessary to explore the clinical implications of these results and the potential of CK in future treatment strategies. This research highlights the promise of CK in addressing significant health issues.https://www.mdpi.com/2075-1729/15/1/41obesityosteoporosisginsenoside CKinflammationlipid and atherosclerosis |
| spellingShingle | Md. Niaj Morshed Reshmi Akter Imran Mahmud Ah-Yeong Gwon Jin Woo Jeang Yeong-Geun Lee Dae Won Park Deok Chun Yang Yeon Ju Kim Se-Chan Kang Experimental Validation of Antiobesogenic and Osteoprotective Efficacy of Ginsenoside CK via Targeting Lipid and Atherosclerosis Pathways Life obesity osteoporosis ginsenoside CK inflammation lipid and atherosclerosis |
| title | Experimental Validation of Antiobesogenic and Osteoprotective Efficacy of Ginsenoside CK via Targeting Lipid and Atherosclerosis Pathways |
| title_full | Experimental Validation of Antiobesogenic and Osteoprotective Efficacy of Ginsenoside CK via Targeting Lipid and Atherosclerosis Pathways |
| title_fullStr | Experimental Validation of Antiobesogenic and Osteoprotective Efficacy of Ginsenoside CK via Targeting Lipid and Atherosclerosis Pathways |
| title_full_unstemmed | Experimental Validation of Antiobesogenic and Osteoprotective Efficacy of Ginsenoside CK via Targeting Lipid and Atherosclerosis Pathways |
| title_short | Experimental Validation of Antiobesogenic and Osteoprotective Efficacy of Ginsenoside CK via Targeting Lipid and Atherosclerosis Pathways |
| title_sort | experimental validation of antiobesogenic and osteoprotective efficacy of ginsenoside ck via targeting lipid and atherosclerosis pathways |
| topic | obesity osteoporosis ginsenoside CK inflammation lipid and atherosclerosis |
| url | https://www.mdpi.com/2075-1729/15/1/41 |
| work_keys_str_mv | AT mdniajmorshed experimentalvalidationofantiobesogenicandosteoprotectiveefficacyofginsenosideckviatargetinglipidandatherosclerosispathways AT reshmiakter experimentalvalidationofantiobesogenicandosteoprotectiveefficacyofginsenosideckviatargetinglipidandatherosclerosispathways AT imranmahmud experimentalvalidationofantiobesogenicandosteoprotectiveefficacyofginsenosideckviatargetinglipidandatherosclerosispathways AT ahyeonggwon experimentalvalidationofantiobesogenicandosteoprotectiveefficacyofginsenosideckviatargetinglipidandatherosclerosispathways AT jinwoojeang experimentalvalidationofantiobesogenicandosteoprotectiveefficacyofginsenosideckviatargetinglipidandatherosclerosispathways AT yeonggeunlee experimentalvalidationofantiobesogenicandosteoprotectiveefficacyofginsenosideckviatargetinglipidandatherosclerosispathways AT daewonpark experimentalvalidationofantiobesogenicandosteoprotectiveefficacyofginsenosideckviatargetinglipidandatherosclerosispathways AT deokchunyang experimentalvalidationofantiobesogenicandosteoprotectiveefficacyofginsenosideckviatargetinglipidandatherosclerosispathways AT yeonjukim experimentalvalidationofantiobesogenicandosteoprotectiveefficacyofginsenosideckviatargetinglipidandatherosclerosispathways AT sechankang experimentalvalidationofantiobesogenicandosteoprotectiveefficacyofginsenosideckviatargetinglipidandatherosclerosispathways |